The primary methods for early PCa screening include measuring levels of prostate-specific antigen (PSA) in human serum, conducting digital rectal examinations, and performing transrectal ultrasound-guided prostate biopsies. This evidence concerns the gene KLK3 and posterior cortical atrophy.